hyperbetalipoproteinemia


Also found in: Dictionary, Thesaurus.

hyperbetalipoproteinemia

 [hi″per-ba″tah-lip″o-pro″-tēn-e´me-ah]
increased accumulation of low-density lipoproteins (β-lipoproteins) in the blood.

hy·per·be·ta·lip·o·pro·te·in·e·mi·a

(hī'pĕr-bā'tă-lip'ō-prō-tē-inē'mē-ă),
Enhanced concentration of β-lipoproteins in the blood.

hyperbetalipoproteinemia

/hy·per·be·ta·lipo·pro·tein·emia/ (-ba″tah-lip″o-pro″te-ne´me-ah) increased accumulation of low-density lipoproteins in the blood.

hyperbetalipoproteinemia

[hī′pərbā′təlip′ōprō′tēnē′mē·ə]
Etymology: Gk, hyper + beta, second letter of Greek alphabet, lipos, fat, proteios, first rank, haima, blood
type II hyperlipoproteinemia, a genetic disorder of lipid metabolism characterized by abnormally high levels of serum cholesterol and the appearance of xanthomas on the tendons of the heels, knees, and fingers. There is a marked tendency to development of atherosclerosis and early myocardial infarction, especially among males. Treatment attempts to reduce blood cholesterol levels in the hope of lowering the risk of early death from heart disease. The patient is usually counseled to avoid most meats, eggs, milk products, and all saturated fats and is encouraged to eat fish, grains, fruits, vegetables, lean poultry, and unsaturated fats. Exercise may be recommended, and drugs may be prescribed in some cases. See also cholesterolemia.

hyperbetalipoproteinemia

(1) Familial hypercholesterolemia, OMIM:143890. 
(2) Type II hyperlipoproteinemia, OMIM:144400.

hyperbetalipoproteinemia

increased accumulation of β-lipoproteins in the blood.
References in periodicals archive ?
So the definition of metabolic syndrome should include reversible metabolic risk factors such as overweight, hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, IFG, IGT, and WCH but not obesity, HT, DM, CHD, PAD, and stroke like terminal diseases.
As a conclusion, the metabolic syndrome includes some reversible indicators such as overweight, hyperbetalipoproteinemia, hypertriglyceridemia, dyslipidemia, IFG, IGT, and WCH for the development of terminal diseases including obesity, HT, DM, PAD, CHD, and stroke.
So definition of the syndrome should include reversible metabolic risk factors such as overweight, WCH, IFG and IGT, hypertriglyceridemia, hyperbetalipoproteinemia, and dyslipidemia but not obesity, HT, DM, CHD, and stroke like terminal diseases.